Clinical and Immunological Results from Phase 1/2 Study of INO-3107 as a treatment for Recurrent Respiratory Papillomatosis Published in Nature Communications
Pipeline-mobile-8-15-23
© Copyright 2025 INOVIO Pharmaceuticals. All rights reserved.
